Duopharma Biotech together with Permodalan Nasional Berhad contribute Ventilators for a Government Hospital;
Three Patient Monitoring Devices, which will be used at the Intensive Care Unit (“ICU”) at Government Hospitals
RM10,000 cash was donated to Orang Asli through Epic Society
RM50,000.00 cash was channeled to Government-Linked Companies’ Disaster Response Network (“GDRN”) to purchase other supplies
KUALA LUMPUR, 13 February 2020 – In an announcement to Bursa Malaysia this evening,
Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma
Biotech” or “Company”) announced a commendable set of unaudited financial results to close off a
strong performance in 2019 with yearly net profit increasing 16 percent to touch RM55.27 million
(2018: RM47.64 million) on higher revenue of RM576.46 million (2018: RM498.72 million).
Kuala Lumpur, December 18, 2019 – Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”) today unveiled its new corporate logo and name at an external rebranding launch. The Company obtained shareholders’ approval for the new corporate identity earlier this year. Duopharma Biotech, which is majority owned by Permodalan Nasional Berhad (PNB), is the largest Malaysian pharmaceutical manufacturer and trading company.
Kuala Lumpur, November 29, 2019 – Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”) unaudited revenue grew 14.52 per cent to RM438.71 million for nine months ended 30 September 2019 (Q3 FY2019), from RM383.09 million in the corresponding period last year, mainly due to the higher demand from private and public health sector.
Kuala Lumpur, September 3, 2019– The ‘Tennis Malaysia First Serve Mini Tennis’ Carnival was in full swing at the Jalan Sultan Abdul Halim’s National Tennis Centre recently, with some 300 students, aged seven to nine, participating in the event organised by the Lawn Tennis Association of Malaysia (LTAM) and sponsored by CHAMPS®, Malaysia’s leading children health supplement brand manufactured and distributed by Duopharma Biotech Berhad, (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”).
Kuala Lumpur, August 30, 2019 – Duopharma Biotech Berhad’s (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”) Board of Directors has recommended a single tier interim dividend of 1.0 sen per share based on paid up capital of 680,106,506 shares amounting to approximately RM6.80 million for the current financial period ended 30 June 2019.
Bangi, Selangor, July 17, 2019 – Duopharma Biotech Berhad (formerly known as CCM Duopharma Biotech Berhad) (“Duopharma Biotech”)’s commitment in enhancing halal integrity for pharmaceutical products continues to attract the interest of various groups in Malaysia, with the latest being the visit by the Negeri Sembilan Mufti and Fatwa office led by the mufti himself, Datuk Hj Mohd Yusof Bin Hj. Ahmad.
Shah Alam, May 31, 2019 – Duopharma Biotech Berhad’s (Duopharma Biotech) (formerly known as CCM Duopharma Biotech Berhad) has accomplished several key milestones in its first year as an independent entity, by continuing to pioneer many firsts in the local pharmaceutical landscape.
Bangi, May 28, 2019 – The holy month of Ramadan is more than abstaining ourselves from eating and drinking from dawn until dusk. It is a time for reflection and focus on religious obligations, which teaches us to be grateful for all the blessings and practice compassion towards the less fortunate.
KUALA LUMPUR, 28 Mei 2019 – Syarikat farmaseutikal terkemuka Duopharma Biotech Berhad (dahulunya di kenali sebagai CCM Duopharma Biotech Berhad) (“Duopharma Biotech”) telah berkerjasama dengan Jabatan Siasatan dan Penguatkuasaan Trafik Polis Diraja Malaysia (PDRM) bagi melancarkan Kempen Op Selamat 15/2019 bersama Proviton sempena musim perayaan ini dengan slogan “Rumah Selamat Sampai ke Destinasi”.